Marcus Joel S
- SEC CIK
- 0001216955
In the past year, 6 open-market purchase filings worth $2.91M and no sales.
Current role at each company
- ARE Alexandria Real Estate Equities, Inc.Executive Chairmanas of Sep 15, 2026
- ITCI Intra-Cellular Therapies, Inc.Directoras of Apr 2, 2025
- APLT Applied Therapeutics, Inc.Directoras of Jun 7, 2024
- KRRO Korro Bio, Inc.Directoras of Aug 19, 2022
- MGTX MeiraGTx Holdings plcDirectoras of Jun 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $2.91M
- 6 filings
- Sold
- –
- 0 filings
- Net
- +$2.91M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Marcus Joel S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARE Alexandria Real Estate Equities, Inc.
Executive Chairman14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)4:44 PM ET | Sep 11 | 4 days | Marcus Joel SExecutive Chairman | PPurchase | +5.00K | $49.68 | +$248.4K | +0.8%597.7K after | |
| Aug 19, 2026 (view filing)4:37 PM ET | Aug 17 | 2 days | Marcus Joel SExecutive Chairman | PPurchase | +5.00K | $46.28 | +$231.4K | +0.9%592.7K after | |
| May 7, 2026 (view filing) | May 6 | 1 day | Marcus Joel SExecutive Chairman | PPurchase | +7.50K | $46.34 | +$347.6K | +1.3%587.7K after | 2 lots |
| May 6, 2026 (view filing) | May 5 | 1 day | Marcus Joel SExecutive Chairman | PPurchase | +7.50K | $42.72 | +$320.4K | +1.3%580.2K after | 3 lots |
| May 5, 2026 (view filing) | May 4 | 1 day | Marcus Joel SExecutive Chairman | PPurchase | +10.0K | $41.02 | +$410.2K | +1.8%572.7K after | |
| Feb 13, 2026 (view filing) | Feb 12 | 1 day | Marcus Joel SExecutive Chairman | PPurchase | +25.0K | $53.92 | +$1.35M | +4.6%562.7K after | 2 lots |
| Feb 28, 2024 (view filing) | Feb 26 | 2 days | Marcus Joel SExecutive Chairman | SSale | −7.50K | $118.92 | −$891.9K | −1.7%429.5K after | |
| May 10, 2023 (view filing) | May 8 | 2 days | Marcus Joel SExecutive Chairman | SSale | −7.50K | $122.20 | −$916.5K | −2.1%351.4K after | |
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Marcus Joel SExecutive Chairman | SSale | −9.00K | $168.00 | −$1.51M | −2.3%388.7K after | |
| Dec 14, 2022 (view filing) | Dec 12 | 2 days | Marcus Joel SExecutive Chairman | SSale | −6.50K | $150.00 | −$975.0K | −1.9%337.0K after |
ITCI Intra-Cellular Therapies, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 (view filing) | Feb 26 | 1 day | Marcus Joel SDirector | SSale | −26.3K | $68.68 | −$1.81M | −39.9%39.7K after | 3 lots |
| Dec 21, 2022 (view filing) | Dec 19 | 2 days | Marcus Joel SDirector | SSale | −5.00K | $50.82 | −$254.1K | −14.6%29.2K after | |
| Nov 8, 2022 (view filing) | Nov 7 | 1 day | Marcus Joel SDirector | SSale | −10.0K | $52.30 | −$523.0K | −22.6%34.2K after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Marcus Joel SDirector | SSale | −10.0K | $59.22 | −$592.2K | −18.4%44.2K after | |
| May 13, 2022 (view filing) | May 12 | 1 day | Marcus Joel SDirector | SSale | −10.0K | $55.00 | −$550.0K | −15.6%54.2K after | |
| Mar 9, 2022 (view filing) | Mar 7-8 | 2 days | Marcus Joel SDirector | SSale | −20.0K | $53.14 | −$1.06M | −40.8%29.0K after | 3 lots |